- Home
- CORT vs ESAB Comparison
CORT vs ESAB Comparison
Compare CORT & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- ESAB
- Stock Information
- Founded
- CORT 1998
- ESAB 1904
- Country
- CORT United States
- ESAB United States
- Employees
- CORT N/A
- ESAB N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- ESAB Office Equipment/Supplies/Services
- Sector
- CORT Health Care
- ESAB Industrials
- Exchange
- CORT Nasdaq
- ESAB Nasdaq
- Market Cap
- CORT 7.6B
- ESAB 7.2B
- IPO Year
- CORT N/A
- ESAB N/A
- Fundamental
- Price
- CORT $75.18
- ESAB $109.64
- Analyst Decision
- CORT Strong Buy
- ESAB Strong Buy
- Analyst Count
- CORT 4
- ESAB 8
- Target Price
- CORT $139.00
- ESAB $141.25
- AVG Volume (30 Days)
- CORT 675.5K
- ESAB 403.5K
- Earning Date
- CORT 10-29-2025
- ESAB 10-28-2025
- Dividend Yield
- CORT N/A
- ESAB 0.37%
- EPS Growth
- CORT N/A
- ESAB 2.07
- EPS
- CORT 1.11
- ESAB 4.17
- Revenue
- CORT $716,080,000.00
- ESAB $2,737,730,000.00
- Revenue This Year
- CORT $30.62
- ESAB $0.81
- Revenue Next Year
- CORT $37.68
- ESAB $6.33
- P/E Ratio
- CORT $67.23
- ESAB $26.18
- Revenue Growth
- CORT 25.71
- ESAB N/A
- 52 Week Low
- CORT $38.68
- ESAB $100.17
- 52 Week High
- CORT $117.33
- ESAB $135.97
- Technical
- Relative Strength Index (RSI)
- CORT 60.68
- ESAB 38.01
- Support Level
- CORT $69.03
- ESAB $107.21
- Resistance Level
- CORT $74.79
- ESAB $119.25
- Average True Range (ATR)
- CORT 2.69
- ESAB 2.76
- MACD
- CORT 0.32
- ESAB -0.36
- Stochastic Oscillator
- CORT 95.68
- ESAB 20.18
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.